from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3360/-

LFCtreatmentdescriptionclass of inhibitor

-0.781

Amikacinug/mL Amikacintranslation

-0.548

Cap5-10ug/mL Capreomycintranslation

-0.798

Rox10-50 ug/mL Roxithromycintranslation

-0.320

SM2-5 ug/mL Streptomycintranslation

-1.229

Tet5-10 ug/mL Tetracyclinetranslation

-0.285

Rif0.2-5ug/mL Rifampicintranscription

-0.558

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.037

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.238

CPZ10-50 ug/mL Chlorpromazinerespiration

0.723

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.085

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.465

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.251

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.414

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.122

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.542

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.272

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.913

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.953

KCN5-20 ug/mL Potassium cyaniderespiration

0.577

NaN30.2-2 mM Sodium aziderespiration

0.476

Nigericin50 uM Nigericinrespiration

-0.189

TRC10-150 ug/mL Triclosanrespiration

-0.826

TRZ10-25 ug/mL Thioridazinerespiration

0.651

Valinomycin0.5-10 uM Valinomycinrespiration

0.743

ZnSO42 mM ZnSO4respiration

0.162

menadione6-10 ug/mL Menadionerespiration

-0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.052

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.251

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.024

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.964

NRP_1Non-replicating persistence stage 1dosRassociated

-0.135

Amp0.2mg/mL AmpicillincellWall

-0.102

Cephalexin20-100 ug/mL CephalexincellWall

-0.211

Cerulenin0.32-5 ug/mL CerulenincellWall

0.148

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.037

EMB10-20 ug/mL EthambutolcellWall

0.172

Eta12-40 ug/mL EthionamidecellWall

-0.323

INH0.2-0.4 ug/mL IsoniazidcellWall

0.068

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.052

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.452

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.074

BZA0.12 mg/mL BenzamidearomaticAmides

-0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.102

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.158

H2O24 mM hydrogen peroxideDNAdamaging

-0.262

Levo10 ug/mL LevofloxacinDNAdamaging

-0.686

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.916

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.398

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.648

UVUV-irradiationDNAdamaging

2.521

ARP41-4 ug/mL Antitubercular compound ARP4?

0.213

Antimycin12.5-50 ug/mL Antimycin A?

0.175

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.268

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.055

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.303

PA8240.2-2 ug/mL PA-824?

1.750

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.309

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.153

Verapamil50 uM Verapamil?

-0.096

mercaptoethanol2 mM 2-Mercaptoethanol?

0.751

methoxatin10-20 ug/mL Methoxatin?